Selective serotonin reuptake inhibitors and isoniazid: Evidence of a potential adverse interaction

Military Medicine

Volumn 166, Issue 12, 2001, Pages 1054-1056

  Doyle, M E ^a   Hicks, D ^a   Aronson, N E ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; ISONIAZID; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NAUSEA; PATIENT COMPLIANCE; SIDE EFFECT; TOXIC HEPATITIS; TUBERCULOSIS;

EID: 0035664359     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/166.12.1054     Document Type: Article

References (13)

1. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: Fluoxetine clinical data and preclinical findings
2. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo
3. Fluoxetine and the serotonin syndrome
4. Sertraline-phenelzine interaction: A serotonin syndrome reaction
5. Danger of MAOI therapy after fluoxetine withdrawal
6. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death
7. Adverse consequences of fluoxetine-MAOI combination therapy
8. Interaction of fluoxetine and selegiline
9. The serotonin syndrome
10. Isoniazid and antidepressants: Is there cause for concern?
11. Medication use by ambulatory elderly: An in-home survey
12. Selective serotonin reuptake inhibitors: Meta-analysis of discontinuation rates
13. Newer antidepressants and the cytochrome P450 system